Abstract

1140PD - Predictive biomarkers for hyper-progression (HP) in response to immune checkpoint inhibitors (ICI) – analysis of somatic alterations (SAs)

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
1413 The overall survival (OS) and progression-free survival (PFS) of hyperprogressive disease (HDP) in lung cancer patients
Youjin Oh ... Timothy Hong
Journal for ImmunoTherapy of Cancer | VOL. 10
Youjin Oh, et. al.Youjin Oh ... Timothy Hong
01 Nov 2022
Comprehensive Genomic Review of TCGA Head and Neck Squamous Cell Carcinomas (HNSCC).
Mario Pérez Sayáns ... Elena Padín Iruegas
Journal of Clinical Medicine | VOL. 8
Mario Pérez Sayáns, et. al.Mario Pérez Sayáns ... Elena Padín Iruegas
07 Nov 2019
Genomic markers associated with hyperprogression in patients with lung cancer treated with immune checkpoint inhibitors.
Eyob Ale Tadesse ... Thomas D Brown
Journal of Clinical Oncology | VOL. 39
Eyob Ale Tadesse, et. al.Eyob Ale Tadesse ... Thomas D Brown
20 May 2021
Molecular alterations with hyperprogression in lung cancer patients treated with immune checkpoint inhibitors in a large health system.
Eyob Ale Tadesse ... Jonathan Hirsch
Journal of Clinical Oncology | VOL. 38
Eyob Ale Tadesse, et. al.Eyob Ale Tadesse ... Jonathan Hirsch
20 May 2020
View more papers

More From: Annals of oncology : official journal of the European Society for Medical Oncology

Paper Title
Journal
Date
Author
Neratinib and ado-trastuzumab emtansine for pretreated and untreated human epidermal growth factor receptor 2 (HER2)-positive breast cancer brain metastases: Translational Breast Cancer Research Consortium trial 022
R.A Freedman ... N.U Lin
Annals of oncology : official journal of the European Society for Medical Oncology | VOL. -
R.A Freedman, et. al.R.A Freedman ... N.U Lin
06 Jul 2024
Primary tumor resection for asymptomatic colorectal cancer with unresectable metastasis: the end of the dilemma
Sebastiano Biondo ... Esther Kreisler
Annals of oncology : official journal of the European Society for Medical Oncology | VOL. -
Sebastiano Biondo, et. al.Sebastiano Biondo ... Esther Kreisler
03 Jul 2024
Challenging immune exhaustion in early recurrent triple-negative breast cancer: pitfalls and hopes
P Tarantino ... S M Tolaney
Annals of oncology : official journal of the European Society for Medical Oncology | VOL. 35
P Tarantino, et. al.P Tarantino ... S M Tolaney
01 Jul 2024
Elevating Cancer on the Global Health Agenda: Towards the 4th High-Level Meeting on NCDs 2025
Raffaella Casolino ... Andrè Ilbawi
Annals of oncology : official journal of the European Society for Medical Oncology | VOL. -
Raffaella Casolino, et. al.Raffaella Casolino ... Andrè Ilbawi
01 Jul 2024
View more papers